HIT Press Club AJMC - Dr. Deneen Vojta

The Orphan Drug Act in the Modern Drug Pricing Era

A deep-learning serial CT response score outperformed conventional imaging measures in predicting OS for patients with advanced NSCLC treated with ICIs.

New Molecular Drivers of HER2 Breast Cancer Resistance: A Q&A With Ateequllah Hayat, PhD

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

City St. George’s researcher Ateequllah Hayat, PhD, explains newly identified mechanisms behind lapatinib resistance in HER2-positive breast cancer.

February 4th 2026

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.

January 27th 2026

Coalition's Conversation: The Employer Perspective

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Tom Belmont, AP, CLU, ChFC, RHU, REBC, president and CEO of the Greater Philadelphia Business Coalition on Health (Series host and moderator) Patrick Henry, PharmD, MBA, clinical advisor at Employers Health Emily Malloy, PharmD, pharmacy resident at Employers Health

Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD

Obesity market overview for employers: data on GLP-1s for obesity, digital solutions, and benefit strategies to control costs and outcomes.

In this Q&A, Na’am Avitzur, MD, discusses how pulmonary fibrosis impacts sexual health and why addressing quality of life matters.

February 2nd 2026

Serial CT Response Score Predicts OS in Patients With Advanced NSCLC Receiving ICIs

A European Respiratory Journal study shows pulmonary fibrosis affects sexual function and quality of life, calling for open clinician-patient conversations.

Related Content

February 5th 2026

The Orphan Drug Act in the Modern Drug Pricing Era

A deep-learning serial CT response score outperformed conventional imaging measures in predicting OS for patients with advanced NSCLC treated with ICIs.

New Molecular Drivers of HER2 Breast Cancer Resistance: A Q&A With Ateequllah Hayat, PhD

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

February 4th 2026

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.

January 27th 2026

Coalition's Conversation: The Employer Perspective

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD

Obesity market overview for employers: data on GLP-1s for obesity, digital solutions, and benefit strategies to control costs and outcomes.

February 2nd 2026